COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 165 filers reported holding COHERUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,049,520 | +106534.8% | 548,000 | +21.8% | 2.18% | +16.0% |
| Q2 2023 | $1,922 | +40.5% | 450,000 | +125.0% | 1.88% | +15.5% |
| Q1 2023 | $1,368 | -1.3% | 200,000 | +14.3% | 1.62% | -1.9% |
| Q4 2022 | $1,386 | -99.9% | 175,000 | -12.5% | 1.66% | -22.8% |
| Q3 2022 | $1,922,000 | +32.7% | 200,000 | 0.0% | 2.14% | +39.2% |
| Q2 2022 | $1,448,000 | -25.2% | 200,000 | +33.3% | 1.54% | -5.2% |
| Q1 2022 | $1,937,000 | -2.9% | 150,000 | +20.0% | 1.63% | +7.9% |
| Q4 2021 | $1,995,000 | -0.7% | 125,000 | 0.0% | 1.51% | +0.6% |
| Q3 2021 | $2,009,000 | +45.3% | 125,000 | +25.0% | 1.50% | +49.9% |
| Q2 2021 | $1,383,000 | +26.2% | 100,000 | +33.3% | 1.00% | +22.7% |
| Q1 2021 | $1,096,000 | +5.1% | 75,000 | +25.0% | 0.81% | -15.8% |
| Q4 2020 | $1,043,000 | – | 60,000 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |